RFK Jr. says no hand in rebuking Replimune drug (REPL:NASDAQ)
Summary
Replimune (REPL) stock rises as Health Secretary Robert F. Kennedy Jr. says he had no hand in rejecting the company's lead drug, RP1. Read more here.
Description
Replimune (REPL) stock rises as Health Secretary Robert F. Kennedy Jr. says he had no hand in rejecting the company's lead drug, RP1. Read more here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source